Indication
Liver Damage
5 clinical trials
5 products
Product
TURALIO™Clinical trial
A Long-term Study to Further Evaluate the Risk of Hepatotoxicity Associated With TURALIO™ (Pexidartinib) TreatmentStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Proof-of-concept Phase II Study to Evaluate the Efficacy and Safety of Prednisone in the Treatment of Idiosyncratic Hepatotoxicity and Its Mechanistic Pathways Through an Integrative Analysis: the DILI-CORT Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2027-12-31
Product
PrednisoneClinical trial
Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic LeukemiaStatus: Recruiting, Estimated PCD: 2023-12-31
Product
LevocarnitineProduct
AcetaminophenClinical trial
Monitoring the HePAtological TOXicity of DrugsStatus: Completed, Estimated PCD: 2020-02-04